Mediator MED23 cooperates with RUNX2 to drive osteoblast differentiation and bone development.
Mediator MED23 cooperates with RUNX2 to drive osteoblast differentiation and bone development.
复制标题
Mediator MED23与RUNX2合作驱动成骨细胞分化和骨骼发育
DOI:
10.1038/ncomms11149
复制
发表时间:
2016-04-01
影响因子:
16.6
通讯作者:
Wang G
中科院分区:
文献类型:
--
作者:
Liu Z;Yao X;Yan G;Xu Y;Yan J;Zou W;Wang G
How lineage specifiers are regulated during development is an outstanding question, and the molecular regulation of osteogenic factor RUNX2 remains to be fully understood. Here we report that the Mediator subunit MED23 cooperates with RUNX2 to regulate osteoblast differentiation and bone development.Med23deletion in mesenchymal stem cells or osteoblast precursors results in multiple bone defects similar to those observed inRunx2+/−mice.In vitro,Med23-deficient progenitor cells are refractory to osteoblast differentiation, andMed23deficiency reducesRunx2-target gene activity without changing Runx2 expression. Mechanistically, MED23 binds to RUNX2 and modulates its transcriptional activity. Moreover,Med23deficiency in osteoprogenitor cells exacerbates the skeletal abnormalities observed inRunx2+/−mice. Collectively, our results establish a genetic and physical interaction between RUNX2 and MED23, suggesting that MED23 constitutes a molecular node in the regulatory network of anabolic bone formation and related diseases.